Takaaki Arigami

Summary

Affiliation: Kagoshima University
Country: Japan

Publications

  1. Arigami T, Natsugoe S, Uenosono Y, Arima H, Mataki Y, Ehi K, et al. Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer. Br J Cancer. 2005;93:688-93 pubmed
    ..We demonstrated a high incidence of micrometastasis and lymphatic invasion and a correlation between them even in pN0 gastric cancer. When planning less invasive treatment, the presence of such occult cancer cells should be considered...
  2. Arigami T, Uenosono Y, Hirata M, Hagihara T, Yanagita S, Ishigami S, et al. Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis. J Surg Oncol. 2010;102:748-52 pubmed publisher
    ..The 5-year survival rate was significantly lower in patients with than without B7-H4 expression (P?=?0.04). The evaluation of B7-H4 expression in blood is a useful tool for predicting the progression of gastric cancer and prognosis. ..
  3. Arigami T, Uchikado Y, Omoto I, Sasaki K, Kita Y, Owaki T, et al. Primary Tumor Score Based on Tumor Depth and Length Predicts Prognosis in Esophageal Squamous Cell Carcinoma. Anticancer Res. 2018;38:5447-5452 pubmed publisher
    ..0001). Multivariate analysis demonstrated that PTS was an independent prognostic factor (p=0.0004). PTS has a clinical utility as a prognostic predictor in patients with ESCC. ..
  4. Kita Y, Mori S, Baba K, Uchikado Y, Arigami T, Idesako T, et al. Mucinous adenocarcinoma emerging in sigmoid colon neovagina 40 years after its creation: a case report. World J Surg Oncol. 2015;13:213 pubmed publisher
    ..Her original surgery, using sigmoid colon to construct the artificial vagina, was 40 years ago This patient's case may contribute to our understanding of carcinogenesis in the colon. ..
  5. Tamotsu K, Okumura H, Uchikado Y, Kita Y, Sasaki K, Omoto I, et al. Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma. BMC Cancer. 2015;15:323 pubmed publisher
    ..Assessment of Aurora-A expression in biopsy specimens maybe useful for regarding the potential utility of CRT therapy for patients with ESCC before treatment. ..
  6. Kawasaki Y, Ishigami S, Arigami T, Uenosono Y, Yanagita S, Uchikado Y, et al. Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer. BMC Cancer. 2015;15:5 pubmed publisher
    ..024). Nrf2 expression was positively associated with aggressive tumor behavior in gastric cancer. This result suggests that Nrf2 expression in gastric cancer is a potential indicator of worse prognosis. ..
  7. request reprint
    Arigami T, Uenosono Y, Ishigami S, Yanagita S, Okubo K, Uchikado Y, et al. Clinical Impact of Stomach-partitioning Gastrojejunostomy with Braun Enteroenterostomy for Patients with Gastric Outlet Obstruction Caused by Unresectable Gastric Cancer. Anticancer Res. 2016;36:5431-5436 pubmed
    ..Our preliminary results suggest that SPGJ-BEE provides an improved long-term quality of life and the early induction of subsequent chemotherapy related with a better prognosis in patients with GOO. ..
  8. request reprint
    Arigami T, Uenosono Y, Ishigami S, Yanagita S, Okubo K, Uchikado Y, et al. Clinical Significance of the Glasgow Prognostic Score in Patients with Gastrointestinal Stromal Tumors. Anticancer Res. 2016;36:6687-6690 pubmed
    ..004 and p=0.024, respectively). The GPS, as well as NIH classification, is a promising blood predictor of disease recurrence in patients with resectable gastric GISTs. ..
  9. Yanagita S, Uenosono Y, Arigami T, Kita Y, Mori S, Natsugoe S. Utility of the sentinel node concept for detection of lateral pelvic lymph node metastasis in lower rectal cancer. BMC Cancer. 2017;17:433 pubmed publisher
    ..The SN concept may be useful for detecting lateral pelvic lymphatic flow and LPSN metastases, including micrometastasis in lower rectal cancer. ..

More Information

Publications15

  1. Ishigami S, Ueno S, Nishizono Y, Matsumoto M, Kurahara H, Arigami T, et al. Prognostic impact of CD168 expression in gastric cancer. BMC Cancer. 2011;11:106 pubmed publisher
    ..These results suggest that cancerous CD168 expression can be used as a prognostic marker of gastric cancer owing to its interactions with stromal hyaluronic acid. ..
  2. Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Ehi K, Arima H, et al. Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer. J Surg Oncol. 2009;99:148-53 pubmed publisher
    ..Thus, levels of VEGF-C and -D expression might be useful for predicting micrometastasis in patients with early gastric cancer. ..
  3. request reprint
    Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Arima H, Hirata M, et al. CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol. 2009;35:19-24 pubmed
    ..0021). Assessment of CCR7 and CXCR4 expression in gastric cancer is a useful tool for predicting lymph node metastatic status including LNMM. ..
  4. Arigami T, Uenosono Y, Hirata M, Yanagita S, Ishigami S, Natsugoe S. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci. 2011;102:1019-24 pubmed publisher
    ..02). Multivariate analysis demonstrated that B7-H3 expression was an independent prognostic factor (P = 0.046). Our results indicate that B7-H3 appears to be a useful blood marker for predicting tumor progression in gastric cancer. ..
  5. Arigami T, Uenosono Y, Ishigami S, Hagihara T, Haraguchi N, Natsugoe S. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer. World J Surg. 2011;35:2051-7 pubmed publisher
    ..001). The B7-H4 coregulatory molecule is a novel prognostic marker related to the T-cell-mediated immune response, and its pathway may be a molecular target for controlling tumor progression in patients with gastric cancer. ..
  6. Arigami T, Uenosono Y, Ishigami S, Hagihara T, Haraguchi N, Matsushita D, et al. Expression of stanniocalcin 1 as a potential biomarker of gastric cancer. Oncology. 2012;83:158-64 pubmed publisher
    ..032 and p = 0.013, respectively). Our data strongly suggest that STC 1 is a potentially useful blood marker for predicting biological tumor aggressiveness in patients with gastric cancer. ..